E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/13/2006 in the Prospect News Emerging Markets Daily.

Israel's Elbit Medical Imaging issues additional NIS 47.6 million in debentures

By Reshmi Basu

New York, July 13 - Elbit Medical Imaging Ltd. said it sold NIS 47.6 million of unsecured non-convertible series A debentures to an Israeli investor.

The new issue is in addition to the NIS 468 million of series A debentures and NIS 59 million of series B debentures, which were sold to investors in Israel between February and June of this year.

The Tel Aviv-based company is engaged principally in the development of commercial and entertainment centers in central and eastern Europe. It is a subsidiary of Europe Israel (M.M.S.) Ltd.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.